A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

A secreted inhibitor of angiogenesis that is controlled by a tumor suppressor gene in hamster cells has been found to be similar to a fragment of the platelet and matrix protein thrombospondin. The two proteins were biochemically similar and immunologically crossreactive and could substitute for one another in two functional assays. Human thrombospondin inhibited neovascularization in vivo and endothelial cell migration in vitro, as does the hamster protein, gp140. gp140 sensitized smooth muscle cells to stimulation by epidermal growth factor, as does human thrombospondin. The thrombospondin gene has been localized on human chromosome 15. These results demonstrate a function for the ubiquitous adhesive glycoprotein thrombospondin that is likely to be important in the normal physiological down-regulation of neovascularization. In addition, they raise the possibility that thrombospondin may be one of a number of target molecules through which a tumor suppressor gene could act to restrain tumor growth.

[1]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[2]  R. Sager.  Tumor suppressor genes: the puzzle and the promise. , 1989, Science.

[3]  H. Kleinman,et al.  Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro , 1989, Cell.

[4]  M. Höök,et al.  Thrombospondin modulates focal adhesions in endothelial cells , 1989, The Journal of cell biology.

[5]  R. Weinberg,et al.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.

[6]  V. Dixit,et al.  Expression and initial characterization of a recombinant human thrombospondin heparin binding domain. , 1989, The Journal of biological chemistry.

[7]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[8]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[9]  T. Deckwerth,et al.  Complete thrombospondin mRNA sequence includes potential regulatory sites in the 3' untranslated region , 1989, The Journal of cell biology.

[10]  N. Bouck,et al.  Loss of cancer suppressors, a driving force in carcinogenesis. , 1989, Chemical research in toxicology.

[11]  R. Nachman,et al.  Thrombospondin: phenomenology to function. , 1989, Progress in hemostasis and thrombosis.

[12]  V. Dixit,et al.  Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo , 1988, The Journal of cell biology.

[13]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[14]  D. Ingber,et al.  Inhibition of angiogenesis through modulation of collagen metabolism. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[15]  A. Gown,et al.  Thrombospondin in early human wound tissue. , 1987, The Journal of investigative dermatology.

[16]  D. Hanahan,et al.  Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene , 1987, Cell.

[17]  F. Baralle,et al.  Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. , 1987, The EMBO journal.

[18]  W. Frazier.  Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells , 1987, The Journal of cell biology.

[19]  D. Mosher,et al.  Interactions of thrombospondin with cells in culture: rapid degradation of both soluble and matrix thrombospondin. , 1987, Seminars in thrombosis and hemostasis.

[20]  J. Bishop.  The molecular genetics of cancer. , 1987, Science.

[21]  S. Santoro,et al.  [24] Isolation and characterization of thrombospondin , 1987 .

[22]  P. Bornstein,et al.  Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Hynes,et al.  The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins , 1986, The Journal of cell biology.

[24]  J. Lawler.  The structural and functional properties of thrombospondin. , 1986, Blood.

[25]  A. Canfield,et al.  The biosynthesis of extracellular-matrix components by bovine retinal endothelial cells displaying distinctive morphological phenotypes. , 1986, The Biochemical journal.

[26]  V. Dixit,et al.  Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. , 1986, The Journal of biological chemistry.

[27]  J. Rowley,et al.  Assignment of the GM-CSF, CSF-1, and FMS genes to human chromosome 5 provides evidence for linkage of a family of genes regulating hematopoiesis and for their involvement in the deletion (5q) in myeloid disorders. , 1986, Cold Spring Harbor symposia on quantitative biology.

[28]  P. Vischer,et al.  Synthesis, intracellular processing and secretion of thrombospondin in human endothelial cells. , 1985, European journal of biochemistry.

[29]  V. Dixit,et al.  Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing , 1985, The Journal of cell biology.

[30]  V. Dixit,et al.  Effects of anti-thrombospondin monoclonal antibodies on the agglutination of erythrocytes and fixed, activated platelets by purified thrombospondin. , 1985, Biochemistry.

[31]  V. Dixit,et al.  A monoclonal antibody against human thrombospondin inhibits platelet aggregation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[32]  N. Bouck,et al.  Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  V. Dixit,et al.  Localization of the hemagglutinating activity of platelet thrombospondin to a 140 000-dalton thermolytic fragment. , 1984, Biochemistry.

[34]  J. Rowley,et al.  Evidence for two distinct c-src loci on human chromosomes 1 and 20 , 1984, Nature.

[35]  A. Clowes,et al.  Inhibition of vascular smooth muscle cell migration by heparin‐like glycosaminoglycans , 1984, Journal of cellular physiology.

[36]  M. Simon,et al.  Chromosomal sublocalization of human c-myb and c-fes cellular onc genes , 1983, Nature.

[37]  P. Bornstein,et al.  Endothelial Cells from Umbilical Vein and a Hemangioendothelioma Secrete Basement Membrane Largely to the Exclusion of Interstitial Procollagens , 1982, Arteriosclerosis.

[38]  J. Rowley,et al.  15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA , 1977, The Lancet.

[39]  P. Majerus,et al.  Isolation and properties of a thrombin-sensitive protein of human platelets. , 1972, The Journal of biological chemistry.